Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Norsk Gjenvinning in connection with its acquisition of MIREC Recycling Solutions AB
Mandate

Vinge advises Norsk Gjenvinning in connection with its acquisition of MIREC Recycling Solutions AB

October 06, 2021 EU, Competition and Regulatory Real Estate and Construction M&A Environmental Law Corporate Commercial

Vinge advises the Norsk Gjenvinning Group in connection with its acquisition of MIREC Recycling Solutions AB, a Swedish leading player within recycling and reuse of electrical equipment (EE waste).

The acquisition is in line with the Norsk Gjenvinning Group's strategy to strengthen its presence in the Nordic region, as well as establish a leading position in the market segment for EE waste.

Vinge’s team mainly consisted of Christina Kokko, Hannah Kajlinger and Gustav Persson (M&A), Johan Cederblad and Lina Österberg (Environment), Lisa Hörnqvist (Commercial agreements), Carl Östlund (Employment), Sebastian Örndahl (Competition), Ulf Pyk (Real Estate), and Klara Lundquist (VDR-assistant).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025